{"id":"https://openalex.org/W7225081707","doi":"https://doi.org/10.25258/ijddt.16.86s.59","title":"Design, Synthesis, and In Vitro Evaluation of Novel Saccharin Derivatives for Anticancer Activity Against Neuroblastoma (SH-SY5Y Cell Line) Through Targeting Anaplastic Lymphoma Kinase (ALK).","display_name":"Design, Synthesis, and In Vitro Evaluation of Novel Saccharin Derivatives for Anticancer Activity Against Neuroblastoma (SH-SY5Y Cell Line) Through Targeting Anaplastic Lymphoma Kinase (ALK).","publication_year":2026,"publication_date":"2026-11-02","ids":{"openalex":"https://openalex.org/W7225081707","doi":"https://doi.org/10.25258/ijddt.16.86s.59"},"language":"en","primary_location":{"id":"doi:10.25258/ijddt.16.86s.59","doi":"https://doi.org/10.25258/ijddt.16.86s.59","is_oa":true,"landing_page_url":"https://doi.org/10.25258/ijddt.16.86s.59","pdf_url":"https://doi.org/10.25258/ijddt.16.86s.59","source":{"id":"https://openalex.org/S4210211336","display_name":"International Journal of Drug Delivery Technology","issn_l":"0975-4415","issn":["0975-4415"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-4"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Drug Delivery Technology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://doi.org/10.25258/ijddt.16.86s.59","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5126210923","display_name":"Navya Reddy Y","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405272806","display_name":"Balaji College of Pharmacy","ror":"https://ror.org/04rapry92","country_code":"IN","type":"education","lineage":["https://openalex.org/I4405272806"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Navya Reddy Y","raw_affiliation_strings":["Balaji College of Pharmacy, Anantapuramu, Andhra Pradesh, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Balaji College of Pharmacy, Anantapuramu, Andhra Pradesh, India","institution_ids":["https://openalex.org/I4405272806"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160346522","display_name":"Sushma Taj SK","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sushma Taj SK","raw_affiliation_strings":["Joginapally B.R. Pharmacy College, Yenkapally, Moinabad, R.R. District, Hyderabad, Telangana, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Joginapally B.R. Pharmacy College, Yenkapally, Moinabad, R.R. District, Hyderabad, Telangana, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160350621","display_name":"Nuthana Prathibha B","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405272806","display_name":"Balaji College of Pharmacy","ror":"https://ror.org/04rapry92","country_code":"IN","type":"education","lineage":["https://openalex.org/I4405272806"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Nuthana Prathibha B","raw_affiliation_strings":["Balaji College of Pharmacy, Anantapuramu, Andhra Pradesh, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Balaji College of Pharmacy, Anantapuramu, Andhra Pradesh, India","institution_ids":["https://openalex.org/I4405272806"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160388754","display_name":"Guggilla Rama Thulasi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405272806","display_name":"Balaji College of Pharmacy","ror":"https://ror.org/04rapry92","country_code":"IN","type":"education","lineage":["https://openalex.org/I4405272806"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Guggilla Rama Thulasi","raw_affiliation_strings":["Balaji College of Pharmacy, Anantapuramu, Andhra Pradesh, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Balaji College of Pharmacy, Anantapuramu, Andhra Pradesh, India","institution_ids":["https://openalex.org/I4405272806"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160339989","display_name":"Magam Divya Tejeswi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405272806","display_name":"Balaji College of Pharmacy","ror":"https://ror.org/04rapry92","country_code":"IN","type":"education","lineage":["https://openalex.org/I4405272806"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Magam Divya Tejeswi","raw_affiliation_strings":["Balaji College of Pharmacy, Anantapuramu, Andhra Pradesh, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Balaji College of Pharmacy, Anantapuramu, Andhra Pradesh, India","institution_ids":["https://openalex.org/I4405272806"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160349907","display_name":"Juturu Vasudha","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405272806","display_name":"Balaji College of Pharmacy","ror":"https://ror.org/04rapry92","country_code":"IN","type":"education","lineage":["https://openalex.org/I4405272806"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Juturu Vasudha","raw_affiliation_strings":["Balaji College of Pharmacy, Anantapuramu, Andhra Pradesh, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Balaji College of Pharmacy, Anantapuramu, Andhra Pradesh, India","institution_ids":["https://openalex.org/I4405272806"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5130891203","display_name":"Thilagesh P","orcid":"https://orcid.org/0009-0000-6073-2770","observed_orcids":["https://orcid.org/0009-0000-6073-2770"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thilagesh P","raw_affiliation_strings":["Sri Shanmugha College of Pharmacy, Sankari, Salem, Tamil Nadu, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sri Shanmugha College of Pharmacy, Sankari, Salem, Tamil Nadu, India","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5160386253","display_name":"Mohamed Akram Ali S","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mohamed Akram Ali S","raw_affiliation_strings":["Sri Shanmugha College of Pharmacy, Sankari, Salem, Tamil Nadu, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sri Shanmugha College of Pharmacy, Sankari, Salem, Tamil Nadu, India","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.72031028,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"16","issue":"86s","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.8574000000953674,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.8574000000953674,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.05700000002980232,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.019099999219179153,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/saccharin-derivatives","display_name":"saccharin derivatives","score":0.9919999837875366},{"id":"https://openalex.org/keywords/sulfonamide-derivatives","display_name":"sulfonamide derivatives","score":0.8040000200271606},{"id":"https://openalex.org/keywords/anaplastic-lymphoma-kinase","display_name":"anaplastic lymphoma kinase","score":0.9190000295639038},{"id":"https://openalex.org/keywords/alk-inhibitors","display_name":"ALK inhibitors","score":0.8349999785423279},{"id":"https://openalex.org/keywords/neuroblastoma","display_name":"neuroblastoma","score":0.9959999918937683},{"id":"https://openalex.org/keywords/sh-sy5y-cells","display_name":"SH-SY5Y cells","score":0.9390000104904175},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.968999981880188},{"id":"https://openalex.org/keywords/molecular-docking","display_name":"molecular docking","score":0.8429999947547913},{"id":"https://openalex.org/keywords/cytotoxicity","display_name":"cytotoxicity","score":0.6230000257492065},{"id":"https://openalex.org/keywords/drug-design","display_name":"drug design","score":0.4180000126361847},{"id":"https://openalex.org/keywords/compound-synthesis","display_name":"compound synthesis","score":0.3959999978542328}],"concepts":[{"id":"https://openalex.org/C2776715637","wikidata":"https://www.wikidata.org/wiki/Q938205","display_name":"Neuroblastoma","level":3,"score":0.7142999768257141},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6736000180244446},{"id":"https://openalex.org/C41847442","wikidata":"https://www.wikidata.org/wiki/Q916723","display_name":"Lipinski's rule of five","level":4,"score":0.6615999937057495},{"id":"https://openalex.org/C117643217","wikidata":"https://www.wikidata.org/wiki/Q17824987","display_name":"Anaplastic lymphoma kinase","level":4,"score":0.6320000290870667},{"id":"https://openalex.org/C2777752497","wikidata":"https://www.wikidata.org/wiki/Q286779","display_name":"IC50","level":3,"score":0.5544999837875366},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.5163000226020813},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.46639999747276306},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.4388999938964844},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.43720000982284546},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.3885999917984009},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.387800008058548},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3862999975681305},{"id":"https://openalex.org/C2780783641","wikidata":"https://www.wikidata.org/wiki/Q738686","display_name":"MTT assay","level":3,"score":0.37929999828338623},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.3750999867916107},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.3698999881744385},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.3587000072002411},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.34049999713897705},{"id":"https://openalex.org/C2778347629","wikidata":"https://www.wikidata.org/wiki/Q4652380","display_name":"ALK inhibitor","level":5,"score":0.33239999413490295},{"id":"https://openalex.org/C41685203","wikidata":"https://www.wikidata.org/wiki/Q1974042","display_name":"Docking (animal)","level":2,"score":0.3172000050544739},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.2953000068664551},{"id":"https://openalex.org/C178910836","wikidata":"https://www.wikidata.org/wiki/Q2196961","display_name":"Molecular model","level":2,"score":0.2786000072956085},{"id":"https://openalex.org/C109650736","wikidata":"https://www.wikidata.org/wiki/Q424440","display_name":"CYP3A4","level":4,"score":0.2761000096797943},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.27390000224113464},{"id":"https://openalex.org/C33618052","wikidata":"https://www.wikidata.org/wiki/Q6013136","display_name":"In vitro toxicology","level":3,"score":0.2646999955177307},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.2630999982357025},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.26179999113082886},{"id":"https://openalex.org/C2777752112","wikidata":"https://www.wikidata.org/wiki/Q903238","display_name":"Lead compound","level":3,"score":0.25429999828338623},{"id":"https://openalex.org/C57992300","wikidata":"https://www.wikidata.org/wiki/Q2066956","display_name":"Potency","level":3,"score":0.251800000667572}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.25258/ijddt.16.86s.59","doi":"https://doi.org/10.25258/ijddt.16.86s.59","is_oa":true,"landing_page_url":"https://doi.org/10.25258/ijddt.16.86s.59","pdf_url":"https://doi.org/10.25258/ijddt.16.86s.59","source":{"id":"https://openalex.org/S4210211336","display_name":"International Journal of Drug Delivery Technology","issn_l":"0975-4415","issn":["0975-4415"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-4"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Drug Delivery Technology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.25258/ijddt.16.86s.59","doi":"https://doi.org/10.25258/ijddt.16.86s.59","is_oa":true,"landing_page_url":"https://doi.org/10.25258/ijddt.16.86s.59","pdf_url":"https://doi.org/10.25258/ijddt.16.86s.59","source":{"id":"https://openalex.org/S4210211336","display_name":"International Journal of Drug Delivery Technology","issn_l":"0975-4415","issn":["0975-4415"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-4"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Drug Delivery Technology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225081707.pdf","grobid_xml":"https://content.openalex.org/works/W7225081707.grobid-xml"},"referenced_works_count":9,"referenced_works":["https://openalex.org/W2020383780","https://openalex.org/W2033898136","https://openalex.org/W2126682311","https://openalex.org/W2152394246","https://openalex.org/W2486083793","https://openalex.org/W2971745421","https://openalex.org/W3109438436","https://openalex.org/W4301397866","https://openalex.org/W4388924381"],"related_works":["https://openalex.org/W4223952669","https://openalex.org/W7135181458","https://openalex.org/W2327798243","https://openalex.org/W4301397866","https://openalex.org/W4390415539","https://openalex.org/W2553768392","https://openalex.org/W7219735953","https://openalex.org/W4394620121","https://openalex.org/W4395678372","https://openalex.org/W2316789833"],"abstract_inverted_index":{"The":[0],"study":[1,219,254],"was":[2,128,159,171],"designed,":[3],"synthesised,":[4],"characterized,":[5],"and":[6,73,124,131,143,161,177,200,206,240,281,293,307,312],"evaluated":[7],"by":[8,174],"using":[9,81],"MTT":[10],"Assay":[11],"as":[12,105,273],"a":[13,49,129],"potential":[14,32],"anticancer":[15,33,106,274],"agent,":[16],"new":[17],"Saccharin-7-Sulphonamide":[18],"derivatives":[19],"will":[20],"be":[21,267],"tested":[22],"on":[23],"human":[24],"Neuroblastoma":[25,213,278],"SY5Y":[26,214],"cancer":[27,215],"cell":[28,216],"lines.":[29],"These":[30],"are":[31,90,282],"agents":[34,275,296],"that":[35,149,193,221,256,276],"target":[36,277],"the":[37,45,58,62,84,87,96,99,102,121,134,147,156,168,184,187,224,291],"Anaplastic":[38],"Lymphoma":[39],"Kinase":[40],"receptor.":[41],"As":[42,93],"part":[43,94],"of":[44,51,86,95,98,101,133,146,186,203,232],"computational":[46],"design":[47,303],"process,":[48],"variety":[50],"software":[52],"tools":[53],"were":[54,111,150,164],"used":[55,160],"to":[56,76,154,166,182,251,266],"generate":[57],"structural":[59],"models":[60],"for":[61,270,285],"synthesized":[63,103,122,195,257],"compounds,":[64],"including":[65],"Chemsketch,":[66],"Swiss":[67,82],"ADME,":[68,83],"Molinspiration,":[69],"OSIRIS":[70],"property":[71],"explorer,":[72],"PyRx.":[74],"According":[75],"Lipinski":[77,88],"rule":[78,89],"predictions":[79],"made":[80],"properties":[85],"not":[91],"violated.":[92],"assessment":[97],"effectiveness":[100],"compounds":[104,123,148,196],"agents,":[107],"molecular":[108,137,144],"docking":[109],"studies":[110],"conducted":[112],"with":[113,228,245,259],"ALK,":[114],"which":[115],"demonstrated":[116,192],"promising":[117,268,283],"binding":[118],"affinities":[119],"between":[120],"ALK":[125,279],"molecules.":[126],"There":[127],"determination":[130],"characterization":[132],"percentage":[135],"yield,":[136],"formula,":[138],"solubility,":[139],"melting":[140],"point,":[141],"appearance,":[142],"formula":[145],"investigated.":[151],"In":[152],"order":[153,181],"confirm":[155],"purity,":[157],"TLC":[158],"Rf":[162],"values":[163,247],"calculated":[165],"determine":[167,183,308],"purity.":[169],"It":[170,189],"further":[172,271,286],"characterized":[173],"IR,":[175],"NMR,":[176],"Mass":[178],"spectroscopy":[179],"in":[180],"nature":[185],"compound.":[188],"has":[190],"been":[191],"all":[194],"exhibit":[197],"anti-cancer":[198,295,309],"activities,":[199],"at":[201],"concentrations":[202],"20,":[204],"40,":[205],"50g/mol,":[207],"SA2":[208],"exhibits":[209],"significant":[210],"efficacy":[211],"against":[212,297],"line.":[217],"This":[218,253],"showed":[220],"CompoundSA2":[222],"exhibited":[223,242],"most":[225],"potent":[226,294],"activity":[227],"an":[229],"IC50":[230,246],"value":[231],"5.253\u00b11.761":[233],"\u00b5/mol,":[234],"whereas":[235],"SA":[236],"1,":[237],"3,":[238],"4,":[239],"5":[241],"moderate":[243],"activities":[244],"ranging":[248],"from":[249],"1":[250],"40\u00b5g/ml.":[252],"suggests":[255],"Saacharin":[258],"Sulphanilamide":[260],"derivatives,":[261],"especially":[262],"SA2,":[263],"may":[264],"prove":[265],"candidates":[269,284],"development":[272],"receptors":[280],"development.":[287],"Aim:":[288],"To":[289,302],"develop":[290],"novel":[292],"neuroblastoma":[298],"[SY5Y-cell":[299],"line]":[300],"Objective:":[301],"molecules,":[304],"synthesize,":[305],"characterize":[306],"activity,acute":[310],"toxicity":[311],"cytotoxicity.":[313]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-11-03T00:00:00"}